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Abstract
Sex reversal can occur in XY humans with only a single functional WT1 or SF1 allele or a duplication of the chromosome
region containing WNT4. In contrast, XY mice with only a single functional Wt1, Sf1, or Wnt4 allele, or mice that over-express
Wnt4 from a transgene, reportedly are not sex-reversed. Because genetic background plays a critical role in testis
differentiation, particularly in C57BL/6J (B6) mice, we tested the hypothesis that Wt1, Sf1, and Wnt4 are dosage sensitive in
B6 XY mice. We found that reduced Wt1 or Sf1 dosage in B6 XYB6 mice impaired testis differentiation, but no ovarian tissue
developed. If, however, a YAKR chromosome replaced the YB6 chromosome, these otherwise genetically identical B6 XY mice
developed ovarian tissue. In contrast, reduced Wnt4 dosage increased the amount of testicular tissue present in Sf1+/2 B6
XYAKR, Wt1+/2 B6 XYAKR, B6 XYPOS, and B6 XYAKR fetuses. We propose that Wt1B6 and Sf1B6 are hypomorphic alleles of testis-
determining pathway genes and that Wnt4B6 is a hypermorphic allele of an ovary-determining pathway gene. The latter
hypothesis is supported by the finding that expression of Wnt4 and four other genes in the ovary-determining pathway are
elevated in normal B6 XX E12.5 ovaries. We propose that B6 mice are sensitive to XY sex reversal, at least in part, because
they carry Wt1B6 and/or Sf1B6 alleles that compromise testis differentiation and a Wnt4B6 allele that promotes ovary
differentiation and thereby antagonizes testis differentiation. Addition of a ‘‘weak’’ Sry allele, such as the one on the YPOS
chromosome, to the sensitized B6 background results in inappropriate development of ovarian tissue. We conclude that
Wt1, Sf1, and Wnt4 are dosage-sensitive in mice, this dosage-sensitivity is genetic background-dependant, and the mouse
strains described here are good models for the investigation of human dosage-sensitive XY sex reversal.
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Introduction
Testis differentiation in humans is gene dosage-sensitive. For
example, heterozygosity for WT1 or SF1 (NR5A1) mutations and
duplications containing WNT4 has been associated with XY sex
reversal (SR) [1–10]. Testis differentiation in humans also
appears to be genetic background-sensitive because fathers who
are heterozygous for SF1 mutations or hemizygous for SRY
mutations can pass these mutations to their heterozygous/
hemizygous XY daughters [4,11,12]. In contrast, initial studies
in mice suggested testis differentiation is dosage-insensitive
because heterozygosity for Wt1 or Sf1 null alleles or transgenic
Wnt4 over-expression did not cause XY SR [13–17]. This
apparent human/mouse species difference led to the hypothesis
that some genetic events leading to testis development differed
between these species [18]. However, given the evidence that in
mice genetic background plays a critical role in testis differen-
tiation [19,20], we examined the possibility that Wt1, Sf1 and/or
Wnt4 would be haploinsufficient for normal testis determination
on specific genetic backgrounds.
Work by our group and others has shown that testis
determination in C57BL/6J (B6) inbred mice is particularly
sensitive to genetic perturbation and a number of inherited
gonadal sex reversal conditions have been identified in which B6
XY mice develop ovarian tissue [19–23]. The founding member of
this group, B6-YPOS sex reversal, occurs when the Y Chromosome
(Chr) from Mus domesticus poschiavinus (YPOS) is transferred to the B6
genetic background, replacing the Mus musculus-derived YB6 Chr
[19]. B6 XYPOS fetal gonads develop as either ovotestes (gonads
that contain both ovarian and testicular tissue) or ovaries, but not
normal testes. The YPOS Chr is not inherently defective, however,
because it is testis-determining when transferred to most other
inbred strain backgrounds, including DBA/2J (D2), BALB/cBy,
C3H/HeJ and 129, or when present in F1 hybrids, such as in
(D26B6)F1 mice [24–27]. Furthermore, not all M. domesticus-
derived Y Chrs (i.e., Sry alleles) behave like YPOS (SryPOS) when
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transferred to B6. For example, testis differentiation in B6 XY
mice containing the BUB/BnJ Y Chr appears to be normal
whereas testis differentiation in B6 XY mice containing the AKR/
J Y Chr is transiently delayed [28]. B6 XYAKR mice do not
develop permanent ovaries or ovotestes like B6 XYPOS mice.
However, if B6 XYAKR mice are heterozygous for either the TOrl
or Thp deletion on Chr 17 they develop bilateral ovaries. In
contrast, B6 XYB6 or B6 XYBUB mice heterozygous for the TOrl
deletion develop testes. Thus, the B6-YAKR consomic strain is
more sensitive to XY sex reversal than the B6 strain. We
previously showed that the transient delay in testicular cord
differentiation is caused by the presence of particular SRY protein
isoforms found in M. domesticus mice and that the reduced
expression of some of these variants, such as the SryPOS allele,
causes permanent sex reversal [29].
Further investigations revealed that B6-YPOS sex reversal occurs
because the Sry testis-determining gene present on the YPOS Chr
does not properly induce testis development if specific interacting
genes, designated tda (testis determining autosomal) genes, are
homozygous for B6 alleles. Two tda loci that differ between the B6
and D2 genomes and play a role in B6-YPOS sex reversal were
mapped to Chrs 2 (tda2) and 4 (tda1) [24]. Intriguingly, the Wt1
(Wilms’ tumor 1) and Sf1 (steroidogenic factor 1, officially Nr5a1;
nuclear receptor subfamily 5, group A, member 1, also known as
Ad4BP, adrenal 4-binding protein) map to the tda2 chromosomal
region andWnt4 (wingless-related MMTV integration site 4) to the
tda1 region. Thus, we investigated Wt1 and Sf1 as candidates for
tda2, and Wnt4 as a candidate for tda1.
The Wt1 and Sf1 genes share a number of characteristics in
addition to those noted above, some of which result from the
fact that Wt1 is a direct activator of Sf1 expression [30]
including: 1) both encode zinc finger transcription factors [31–
33]; 2) both are expressed in XX and XY mouse urogenital
ridges from about embryonic day (E) 9.5 until E12.5, when
expression becomes sexually dimorphic and cell-type restricted;
and 3) the gonad progenitor (i.e., genital ridge) is initially
present in fetal mice that are homozygous for a null allele of
either gene, but differentiation of the genital ridge does not
progress and it regresses via apoptosis [14–17]. The Wnt4 gene
encodes a member of the WNT family of secreted signaling
molecules that regulate cell-cell interactions during develop-
ment. Wnt4 is initially expressed in XX and XY genital ridges;
thereafter expression is down-regulated in XY gonads but
maintained in XX gonads [34]. Homozygosity for a Wnt4 null
mutation causes partial sex reversal of XX gonads resulting in
the development of a testis-like coelomic vessel and the presence
of cells expressing steroidogenic enzymes [34,35]. In contrast,
the gonadal phenotype in homozygous Wnt4 null XY mice is
relatively less severe; the gonads develop as testes, but the cords
are initially fewer in number and disorganized [36]. To our
knowledge, Wnt4 heterozygotes have no reported gonad
differentiation defects. In XY mice, transgenic Wnt4 over-
expression also causes testis differentiation defects but not sex
reversal [13,35].
To examine the possibility that the Wt1, Sf1, and Wnt4 genes
would be haploinsufficient on the B6 genetic background, we
transferred null alleles to the B6 and D2 backgrounds and
determined if reduced dosage influenced gonadal development in
XYB6 and XYAKR mice. Gonad morphology and marker gene
expression in mutant versus normal fetal mice was analyzed using
immunohistochemistry and confocal microscopy, RNA in situ
hybridization, and quantitative RT-PCR. The results of these
experiments indicated that testis differentiation was compromised
at a very early stage and that Sry expression was significantly
reduced in Wt1+/2 or Sf1+/2 B6 XYAKR but not in Wt1+/2 or
Sf1+/2 (D26B6)F1 XYAKR fetal gonads. We also found that testis
development was mostly rescued in Wt1+/2 and Sf1+/2 B6
XYAKR fetuses that contained two Sry alleles. These results are
consistent with the hypothesis that the Wt1B6 and Sf1B6 alleles
behave as hypomorphic alleles of testis-determining pathway genes
in B6 XY mice if other genes in the genome are homozygous for
the B6 allele. In contrast, reduced Wnt4 dosage did not exacerbate
the transient delay in testis differentiation in B6 XYAKR gonads
but rather appeared to ameliorate the phenotype, which suggests
that the B6-derived Wnt4 allele (Wnt4B6) is a hypermorphic allele
of a gene in the ovary determination pathway. We also found that
B6 Wt1+/2 XYAKR, B6 Sf1+/2 XYAKR, and B6 XYPOS fetuses
with reduced Wnt4 dosage developed more testicular tissue than
Wnt4+/+ fetuses. These data are consistent with the hypothesis
that Wnt4B6 is an early functioning allele of an ovary-determining
gene that antagonizes testis differentiation in XY mice. Expression
of Wnt4 and four other ovary-biased or ovary-specific genes was
found to be elevated in E12.5 B6 vs. D2 XX ovaries. Together,
our results suggest that B6 mice are sensitive to XY sex reversal
compared to D2 mice because genes in the ovary determination
pathway function earlier in the B6 genome than they do in the D2
genome.
The results reported here show that the Wt1, Sf1, and Wnt4
genes are dosage-sensitive during mouse primary sex determina-
tion, as they are in humans, and that this effect is modulated by
genetic background in the mouse, as is probably the case in
humans. We propose that the dosage-sensitive C57BL/6 XY
mouse strains described here are powerful models for further
investigation of human dosage-sensitive XY sex reversals. In
addition, our results support the candidacy of Wt1, Sf1, and Wnt4
as tda genes, and suggest the testable hypothesis that B6 XYPOS sex
reversal is cause by the additive effects of: 1) hypomorphic Wt1B6
and Sf1B6 alleles, and reduced activation of the testis differentiation
pathway, 2) a hypermorphic Wnt4B6 allele and hyperactivation of
the ovary differentiation pathway, and 3) reduced function and
expression of the SryPOS allele.
Author Summary
It has been proposed that mice do not adequately model
human disorders of sex development because testis
determination is gene dosage-sensitive in humans, but
initial studies suggested it is gene dosage-insensitive in
mice. For example, XY humans with reduced functional
WT1 or SF1 gene-dosage or increased WNT4 gene-dosage
can be sex reversed, whereas the equivalent XY mice were
not sex-reversed on the genetic backgrounds previously
reported. However, because testis determination in C57BL/
6J mice is very sensitive to disruption, we tested the
hypothesis that these genes are dosage-sensitive in
C57BL/6J XY mice. We found that C57BL/6J-YAKR mice
with reduced Wt1 or Sf1 gene-dosage were sex-reversed,
whereas decreased Wnt4 gene-dosage partially rescued
testis development in four genetic systems where C57BL/
6J XY mice develop ovarian tissue. Our results demonstrate
that Wt1, Sf1, and Wnt4 are dosage-sensitive in mice, that
genetic background affects this sensitivity (as we suspect
is true in humans), and that the mouse models described
here are good models for human dosage-sensitive sex
reversal. The results from these and other experiments
lead to the hypothesis that the Wt1 and/or Sf1 alleles
found in C57BL/6J mice are relatively ‘‘weak’’ testis-
determining genes and their Wnt4 allele is a hyperactive
ovary-determining gene.
Modeling Dosage-Sensitive Sex Reversal in Mice
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Results
Wt1+/2 and Sf1+/2 B6 XYAKR mice are sex-reversed
To examine the possibility that Wt1 and/or Sf1 would be
haploinsufficient on the B6 genetic background and to investigate
their candidacy as tda genes, we transferred null alleles to the B6
and D2 backgrounds and determined if reduced dosage influenced
gonadal development in XYB6 and XYAKR mice. We reasoned
that if the B6 alleles of Wt1 and/or Sf1 function as hypomorphs in
the testis determination pathway, then further reducing their
dosage in B6 XY mice should cause sex reversal, whereas reducing
their dosage in D2 XY mice should not. Sex reversal was not
evident in Wt1+/2 or Sf1+/2 B6 or D2 XY weanling or adult
mice, and the mice were fertile. To increase the sensitivity of
the genetic background to sex reversal, we mated Wt1 +/2 and
Sf1+/2 B6 XX females to B6 XYAKR males. Based on the
external sexual phenotype of 39 Wt1+/2 B6 XYAKR mice
examined, 20 presented as male, 11 as hermaphrodite, and 8 as
female (Table 1). In contrast, of the 20 Sf1+/2 B6 XYAKR
offspring, none presented as male, 4 as hermaphrodite, and 16
as female. We noted a deficiency in the expected number of B6
Sf1+/2 animals recovered, regardless of chromosomal sex. To test
if these XY sex reversals were dependent on genetic background
like B6-YPOS sex reversal, offspring were analyzed from mating
Wt1+/2 B6 XX females to AKR/J XYAKR males and Sf1+/2
D2 XX females to B6 XYAKR males. (D2 Wt1+/2 mice were not
available when these analyses were performed but similar results
were obtained in the analysis of gonad morphology in E14.5–16
fetuses when mating Wt1+/2 D2 XX females to B6 XYAKR
mice, Table 2.) In F1 hybrids, the heterozygous XY offspring
presented as normal males and the number of Sf1+/2 (D26B6)F1
offspring recovered was Mendelian. We conclude that Wt1+/2
and Sf1+/2 B6 XYAKR mice are sex reversed, Sf1+/2 B6 mice
have reduced viability, and both sex reversal and reduced viability
are sensitive to genetic background. These results also indicate that
the sex reversal phenotype is stronger in Sf1 mutants because more
Sf1+/2 than Wt1+/2 B6 XYAKR mice presented as females and
hermaphrodites.
Gonad morphology in E14.5–16 fetuses was examined because
assessment of external sexual phenotype does not distinguish
between primary and secondary sex reversal, and thus is only an
estimate of the true sex reversal frequency. At this developmental
stage small amounts of ovarian tissue are visually apparent in
ovotestes and the initial delay in testicular cord development has
resolved in B6 XYAKR fetuses, thus preventing the misclassifica-
tion of the gonad as an ovotestis. All Wt1+/2 B6 XYB6, Wt1+/2
(B66D2)F1 XYAKR and Wt1+/2 (D26B6)F1 XYAKR gonads
analyzed were testes (Figure S1 and Table 2). In contrast,
approximately half of the 48Wt1+/2 B6 XYAKR gonads analyzed
were ovotestes (23) or ovaries (5), and half were normal (8) or
abnormal testes (12). Similarly, all Sf1+/2 B6 XYB6 and Sf1+/2
(D26B6)F1 XYAKR gonads analyzed were testes, whereas the 33
Sf1+/2 B6 XYAKR gonads analyzed were ovotestes (3) or ovaries
(31). These results are consistent with the weanling analysis and
show that sex reversal is the result of primary (gonadal) sex
reversal.
Morphological and marker gene analysis of E13.5
Wt1+/2 and Sf1+/2 B6 XYAKR gonads
To gain further insight into the mechanism of sex reversal in
Wt1+/2 and Sf1+/2 B6 XYAKR gonads, whole-mount immu-
nohistochemistry (WIHC, Figure 1) and whole-mount RNA in situ
hybridization (WISH, Figure 2) were used to analyze morphology
and marker gene expression in E13.5 gonads. Overall, the
morphological analyses were consistent with the E14.5–16
analyses: Wt1+/2 B6 XYAKR gonads were classified as ovaries,
ovotestes and testes and Sf1+/2 B6 XYAKR gonads were classified
as ovaries and ovotestes. The Wt1+/2 and Sf1+/2 B6 XYAKR
gonads that developed as ovaries or ovotestes were phenotypically
indistinguishable regardless of which gene was mutant. However,
some Wt1+/2 B6 XYAKR gonads appeared to be very similar in
morphology and marker gene expression pattern to those observed
in control +/+ B6 XYAKR gonads, whereas none of the Sf1+/2 B6
XYAKR gonads were phenotypically similar to +/+ B6 XYAKR
gonads.
Generally, Wt1+/2 and Sf1+/2 B6 XYAKR gonads that
developed as ovaries were morphologically indistinguishable from
normal XX ovaries and strongly expressed ovary-specific markers,
such as FOXL2 (Figure 1F), Wnt4 (Figure 2F), Fst (data not shown)
and Bmp2 (data not shown) in a pattern similar to XX ovaries.
Additionally, XY ovaries generally did not express testis-specific
Sertoli cell markers, such as AMH (Figure 1F) or SOX9 (data not
shown), or Leydig cell markers, such as Ptch1 (Figure 2L), or
markers such as GATA4, WT1 (data not shown) or FGFR2
(Figure 1L) in a testis-like pattern. However, about 20% of XY
mutant gonads that had ovarian morphology contained cells that
expressed Sertoli cell-specific markers, such as AMH or SOX9
(data not shown), or expressed markers, such as PDGFRa and
FGFR2 in a testis-like pattern (Figure 1I). However, these cells
were not organized in a pattern that resembled testicular cords.
We conclude that Sertoli cell differentiation was initiated in some
XY gonads that were morphologically ovarian, but was insufficient
to initiate or sustain cord formation.
In Wt1+/2 and Sf1+/2 B6 XYAKR ovotestes, testis markers
generally were expressed in central regions containing cords
whereas ovary markers were expressed at the anterior and
posterior poles within regions lacking cords. For example,
Figure 1C shows part of an ovotestis in which the central region
Table 1. External sexual phenotype of Wt1+/2 and Sf1+/2 weaning age mice.
XY pups
Maternal
genotype
Paternal
genotype
+/2
Females
+/2
Hermaphrodites
+/2
Males Total +/2XY pups
Total
XY pups
B6 Wt1+/2 B6 +/+ XYAKR 8 (21%) 11 (28%) 20 (51%) 39 81
B6 Wt1+/2 AKR +/+ XYAKR 0 (0%) 0 (0%) 20 (100%) 20 47
B6 Sf1+/2 B6 +/+ XYAKR 16 (80%) 4 (20%) 0 (0%) 20 95a
D2 Sf1+/2 B6 +/+ XYAKR 0 (0%) 0 (0%) 13 (100%) 13 18
aApproximately 30% of B6 Sf1+/2 pups die prior to weaning.
doi:10.1371/journal.pgen.1002569.t001
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contained cords and strongly expressed AMH, while the adjacent
posterior region lacked cords and expressed FOXL2. Figure 2J
shows an ovotestis that expressed Ptch1 in the central region that
contained testicular cords, but not in the ovarian regions at the
anterior and posterior poles. [Ptch1 expression in ovotestes was not
as strong as that observed in B6 XYAKR control gonads (compare
Figure 2H and 2J)]. Conversely, Figure 2D shows an ovotestis
expressing Wnt4 in the anterior and posterior regions, but not in
the central testicular region. Occasionally, testis- and ovary-
specific markers were expressed in the same region (Figure 1E),
where FOXL2 expression was detected in specific cells within a
region containing well-formed testicular cords and strongly
expressing the Sertoli cell marker AMH. We noted a few cells
that appeared to express both AMH and FOXL2 (Figure S2A).
However, because only whole-mount tissue was examined and
because AMH is localized to the cell surface and FOXL2 to the
nucleus, we were not able to exclude the possibility that the
expression was in adjacent cells. Nevertheless, it is possible that
some supporting cell progenitors can express both granulosa and
Sertoli cell markers under certain conditions.
Because Wt1 is functionally upstream of Sf1 and is necessary for
the initiation of Sf1 expression [30], we examined SF1 expression
in Wt1+/2 B6 XYAKR gonads using WIHC and found that
expression levels appeared normal (Figure 1N–1O). Additionally,
quantitative real-time RT-PCR (qRT-PCR) analysis did not detect
a significant difference in Sf1 expression in E12 gonads from
Wt1+/2 B6 XYAKR vs. +/+ B6 XYAKR fetuses (data not shown).
On the other hand, Wnt4 expression appeared to be reduced in
Wt1+/2 and Sf1+/2 B6 XX ovaries compared to +/+ B6 XX
ovaries, and Ptch1 expression was strongly reduced in Wt1+/2 B6
XX and B6 XY mesonephroi (Figure 2). Overall, the morpholog-
ical and marker gene expression analyses showed that the testis
determination pathway is aberrant at an early stage, that the
ovarian pathway is activated in Wt1+/2 and Sf1+/2 B6 XYAKR
gonads, and that gene expression is affected in both XX and XY
heterozygous gonad/mesonephros complexes.
A multigene qRT-PCR strategy was used to quantify gene
expression changes in E12 +/2 vs. +/+ B6 XYAKR gonads, and
E14 +/2 ovaries vs. +/+ B6 XYAKR testes (Table 3). These
quantitative results were consistent with the morphological and
marker gene analyses. For example, Adamts19, an ovary-specific
gene, was significantly up-regulated in E14 Wt1+/2 and Sf1+/2
B6 XYAKR ovaries vs. +/+ B6 XYAKR control testes, and Cyp11a1
and Cyp17a1, both Leydig cell specific genes, were expressed at
significantly lower levels in Wt1+/2 and Sf1+/2 B6 XYAKR
ovaries.
Ovary-specific markers are expressed at the anterior and
posterior of B6 XYAKR gonads
During analysis of marker gene expression in E13.5 Wt1+/2
and Sf1+/2 B6 XYAKR gonads using WIHC and WISH we
observed the expression of ovary-specific somatic cell markers in
gonads from +/+ B6 XYAKR fetuses. As expected, testis-specific
markers, such as SOX9, AMH and Ptch1, were expressed in the
central regions that contained testicular cords (Figure 1, Figure 2,
and Figure S2). However, FOXL2, Wnt4, and Fst often were
expressed in the anterior and posterior regions that lacked cords
(Figure 1, Figure 2, Figure S2, and data not shown), indicating
that the ovary differentiation pathway was activated in these
regions. WISH analysis of the meiotic germ cell markers Stra8
and Rec8 [37] and the ovary-specific somatic cell marker Irx3 [38]
was used to determine if activation of the ovary differentiation
pathway extended to the germ cells and to quantify the
occurrence of ovary-specific marker gene expression (Figure
S2B). We found that 11 of 13 B6 XYAKR gonads clearly
expressed either Stra8 or Rec8 at one or both poles and that 7 of 7
gonads expressed Irx3 at both poles. In the 9 gonads where Stra8
or Rec8 were expressed at both poles, expression was higher at the
anterior pole than the posterior pole, suggesting that the anterior-
to-posterior wave of meiotic germ cell gene expression is
maintained despite the presence of intervening testicular tissue
[37]. It is important to note that testicular cords are present
throughout B6 XYAKR gonads after about E14.5. Therefore,
these results are consistent with the idea that B6 XYAKR gonads
develop as transient ovotestes [39,40].
Testis and adrenal gland development is abnormal in B6
XYB6 fetuses that are double-heterozygous for Wt1 and
Sf1
Because the Wt1+/2 and Sf1+/2 B6 XYAKR sex reversal
phenotypes appear to be very similar and becauseWt1 is necessary
for activation of Sf1 expression in fetal gonads [30], we examined if
B6 XYB6 mice were sex reversed when double heterozygous for
Wt1 and Sf1 (Wt1+/2; Sf1+/2). We first attempted to ascertain
the external sexual phenotype of the double heterozygotes at
weaning. However, no Wt1+/2; Sf1+/2 mice were recovered
among the 84 progeny from B6 Wt1+/26B6 Sf1+/2 matings
(Table 4). Because our previous results suggested that lethality
Table 2. Gonad phenotype in E14.5–16 Wt1+/2 and Sf1+/2 XY fetuses.
E14.5–16 XY gonads
Maternal
genotype
Paternal
genotype
+/2
Ovaries +/2 Ovotestes
+/2
Testes
+/2 Abnormal
testesa Total +/2 XY gonads
B6 +/+ B6 Wt1+/2 XYB6 0 (0%) 0 (0%) 28 (100%) 0 (0%) 28
B6 Wt1+/2 B6 +/+ XYAKR 5b (10%) 23 (48%) 8 (17%) 12 (25%) 48
B6 Wt1+/2 D2 +/+ XYAKR 0 (0%) 0 (0%) 24 (100%) 0 (0%) 24
D2 Wt1+/2 B6 +/+ XYAKR 0 (0%) 0 (0%) 12 (100%) 0 (0%) 12
B6 +/+ B6 Sf1+/2 XYB6 0 (0%) 0 (0%) 20 (100%) 0 (0%) 20
B6 Sf1+/2 B6 +/+ XYAKR 31 (91%) 3 (9%) 0 (0%) 0 (0%) 34
D2 Sf1+/2 B6 +/+ XYAKR 0 (0%) 0 (0%) 14 (100%) 0 (0%) 14
aCord development is somewhat delayed at the anterior and/or posterior ends but the gonad is not an obvious ovotestis.
bTwo were abnormally shaped but no testicular cords were evident.
doi:10.1371/journal.pgen.1002569.t002
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could be sensitive to genetic background, progeny from B6 Wt1+/
26D2 Sf1+/2 matings were analyzed. Among the 23 offspring
were 4 Wt1+/2; Sf1+/2 mice, indicating that lethality was
rescued in (B66D2)F1 hybrids. To determine at which develop-
mental stage the lethality occurred, E14.5–15.5 fetuses from B6
Wt1+/26B6 Sf1+/2 matings were analyzed. Among the 12
offspring were 3 Wt1+/2; Sf1+/2 mice (2 XY and 1 XX),
indicating that lethality occurred between E15.5 and weaning.
Histological examination of the three Wt1+/2; Sf1+/2 fetuses
showed that each had bilateral adrenal agenesis, which likely
would cause neonatal lethality (Figure 3A and 3B). Both of the
Wt1+/2; Sf1+/2 XY fetuses had bilateral testes that appeared
morphologically normal, but were smaller than those in wild-type
XY littermates.
To extend these observations, gonad development was
examined in E13.5 fetuses from B6 Wt1+/26B6 Sf1+/2
matings using WIHC (Figure 3C–3J). Of the 15 fetuses
examined, 7 were Wt1+/2; Sf1+/2, which is consistent with
the E14.5–15.5 survival data. Of the 9 XYB6 fetuses, 4 were
Wt1+/2; Sf1+/2, 4 were Wt1+/+; Sf1+/2, and 1 was Wt1+/+;
Sf1+/+. All 8 Wt1+/2; Sf1+/2 XY gonads were classified as
ovotestes, with large central testicular regions (Figure 3I and 3J).
(Ovotestes in E13.5 double heterozygous fetuses appear to
resolve into testes at later stages because the gonads in E14.5–
15.5 double heterozygous fetuses do not contain ovarian tissue.)
The 8 gonads from Wt1+/+; Sf1+/2 XY fetuses were classified
as testes but their cords appeared to be less well developed and
more disorganized than +/+ B6 XY gonads (Figure 3). None of
the XY offspring from these intercrosses were Wt1+/2; Sf1+/+,
so we examined gonad development in E13.5 Wt1+/2 B6 XYB6
fetuses generated from B6 Wt1+/26B6 +/+ XYB6 crosses. All 6
gonads from Wt1+/2 B6 XYB6 fetuses were classified as testes.
However, their cords appeared to be less well-developed and
more disorganized than normal B6 XY gonads: 4 displayed
disorganized anterior and posterior poles and 2 had disorganized
posterior poles (Figure 3E and 3F). In comparison, of the 6
gonads from +/+ B6 XYB6 fetuses, 2 had testicular cords
throughout and 4 had disorganized posterior poles. In summary,
the degree of testicular cord development in the E13.5 B6 XYB6
gonads could be ranked from most complete to least complete as:
Sf1+/+; Wt1+/+.Sf1+/+; Wt1+/2.Sf1+/2; Wt1+/+.Sf1+/
2; Wt1+/2. These results indicate that testis development is
compromised in Wt1+/2 and Sf1+/2 B6 XY fetuses, even in
the absence of the YAKR Chr, and that testis development is
further compromised in mice that are double heterozygous for
Wt1 and Sf1 null alleles.
Sry expression is reduced in Wt1+/2 and Sf1+/2 B6
XYAKR gonads and sex reversal is partially rescued by
increased Sry dosage
Because the morphological and marker gene expression
analyses in E13.5 gonads suggested an early defect in the testis
determination pathway, Sry expression in E11.5 Wt1+/2 and
Sf1+/2 B6 XYAKR vs. +/+ B6 XYAKR gonad/mesonephros
complexes was quantified. (Sry is not expressed in the mesoneph-
ros.) During peak Sry expression (E11.75), transcript levels in both
mutants were less than 50% of the controls. We found that Sry
transcript levels were reduced in Wt1+/2 vs. +/+ samples at
E11.25 (15–17 ts, t24 = 2.224 , p,0.0179), E11.5 (18–20 ts,
t25 = 3.653, p,0.0012), and E11.75 (21–23 ts, t3 = 11.51,
p,0.0014) but not significantly different at E12.0 (24–26 ts,
Figure 4A). Sry transcript levels also were reduced in Sf1+/2 vs. +/
+ samples at E11.5 (18–20 ts, t29 = 2.125, p,0.0422) and E11.75
(21–23 ts, t5 = 6.142, p,0.0016), but were not significantly
different at E11.25 (15–17 ts) or E12.0 (24–26 ts, Figure 4A).
These results suggest that sex reversal in Wt1+/2 and Sf1+/2 B6
XYAKR gonads is at least partially due to a failure to sufficiently
up-regulate Sry expression and properly initiate the testis
determination pathway. However, because pairwise comparisons
between Wt1+/2 vs. Sf1+/2 samples did not reveal significant
differences in Sry expression at any of the embryonic stages
analyzed, differences in the level of Sry expression do not explain
the differences in the severity of the Wt1+/2 and Sf1+/2
phenotypes.
To test the hypothesis that sex reversal in Wt1+/2 and
Sf1+/2 B6 XYAKR gonads is due, at least in part, to reduced Sry
expression, gonad morphology was examined by WIHC in
gonads from E13.5 fetuses that had increased Sry dosage due to
the presence of the YAKR,Sxr Chr. [Classification was done
independently by two investigators (SMC and KHA)]. This
rearranged Y Chr carries two Sry alleles, one from the AKR/J
inbred strain (M. domesticus) and one from the RIII inbred strain
(M. musculus). Gonads in Wt1+/2 and Sf1+/2 B6 XYAKR,Sxr
fetuses consistently developed more testicular tissue than
gonads in Wt1+/2 and Sf1+/2 B6 XYAKR fetuses; however,
it appeared that cord differentiation in the Wt1+/2 and Sf1+/2
B6 XYAKR,Sxr gonads was not completely normal (Figure 4B,
Table 5). Of the 8 Wt1+/2 B6 XYAKR,Sxr gonads analyzed, 7 were
classified as abnormal testes because the testicular cords appeared to
be more disorganized and less well developed than those in +/+ B6
XYAKR,Sxr gonads. In fact, these cords appeared to be similar to the
abnormal cords inWt1+/2 B6XYB6 testes. One of theWt1+/2 B6
Figure 1. WIHC analysis of morphology and marker expression inWt1+/2 and Sf1+/2 B6 XYAKR E13.5 gonads. (A–L). Confocal images of
gonad/mesonephros complexes with gonads shown above and mesonephroi below the white dotted line (206magnification). Heterozygous XY
gonads differentiated as ovotestes (C), ovaries (F, L, O), or gonads that were morphologically ovarian but expressed testicular markers (I). TheWt1+/2
XY ovotestis in (C) expressed AMH, a Sertoli cell marker, in the central region containing testicular cords but not at poles that lacked cords. FOXL2, a
granulosa cell marker, was expressed at the poles. FOXL2 also was expressed in isolated cells within regions containing testicular cords in B6 XYAKR
gonads (E). Heterozygous XY ovaries (F, L, O) expressed ovarian but not testicular markers. The Wt1+/2 XY ovary in (F) expressed FOXL2 but not AMH
throughout. The Sf1+/2 XY ovary in (L) expressed FGFR2 on the surface of somatic cells (ovarian pattern) but did not have cells with nuclear
localization of FGFR2 (testicular pattern, note localization in Sertoli cells (H, K)). The Wt1 +/2 XY gonad in (I) was ovarian morphologically but
contained many cells with nuclear localization of FGFR2. These cells were not organized into testicular cords. PDGFRa was expressed at high levels in
the coelomic epithelium of B6 XYAKR gonads (H, K) and at lower levels in interstitial cells of B6 XX (G, J) and XYAKR (H, K) gonads. Ovotestes, expressed
PDGFRa at high levels in the coelomic epithelium of regions containing cords and at lower levels in regions without cords (data not shown). The
heterozygous XY ovary in (L) expressed PDGFRa in a pattern similar to XX ovaries. The masculinized ovary in (I) expressed PDGFRa in a testis-like
pattern. (M–O) Confocal images showing SF1 expression in gonads (406magnification). At this stage, SF1 is expressed at fairly equal levels in all
somatic cells in wild-type XX ovaries (M). In wild-type testes, expression is up-regulated in Sertoli cells (arrowheads) within testis cords (outlined with
white dotted line) and in specific interstitial cells (double arrowheads), while it is down-regulated in most other interstitial cells (N). The expression of
SF1 in Wt1+/2 XY ovaries (O) resembled that of wild-type XX ovaries as expression was uniform in all somatic cells. Note that overall SF1 expression
levels were similar in normal XX (M) vs. Wt1+/2 XY (O) ovaries.
doi:10.1371/journal.pgen.1002569.g001
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XYAKR,Sxr gonads was classified as an ovotestis because it lacked
cords in a small region at the posterior pole and had disorganized
testicular cords in the remainder of the gonad. Of the 8 Sf1+/2 B6
XYAKR,Sxr gonads analyzed, 3 were classified as abnormal testes,
with testicular cords throughout the gonad, and 5 were classified as
ovotestes due to the absence of testicular cords at the posterior pole.
The cords in these 8 gonads also were somewhat disorganized and
less differentiated. In contrast, all 17 of the +/+ B6 XYAKR,Sxr
gonads examined developed robust, well-organized testicular cords
throughout the anterior, center and posterior regions. These data
indicate that increasing Sry dosage in Wt1+/2 and Sf1+/2 B6
XYAKR gonads by replacing the YAKR Chr with the YAKR,Sxr Chr
dramatically increased the amount of testicular tissue that develops,
but did not fully rescue cord differentiation.
Figure 2. WISH analysis of the ovary somatic cell marker Wnt4 and the testis Leydig cell marker Ptch1 in E13.5 gonad/mesonephros
complexes. Wnt4 was expressed throughout +/+ XX ovaries, as expected (A), and at the anterior and/or posterior poles of +/+ B6 XYAKR gonads in
the regions without cords, but not in the central region containing cords (B). Expression was detected at the anterior and/or posterior poles ofWt1+/2
(D) and Sf1+/2 (data not shown) B6 XYAKR ovotestes and throughout Wt1+/2 (data not shown) and Sf1+/2 B6 XYAKR ovaries (F). Wnt4 expression was
reduced in B6Wt1+/2 XX (C) and Sf1+/2 XX (E) ovaries compared to B6Wt1+/+ XX (A) ovaries. Expression also was reduced in B6Wt1+/2mesonephroi
(C and D), but not in Sf1+/2mesonephroi (E and F). Ptch1 expression was restricted to central regions containing testicular cords in +/+ B6 XYAKR gonads
(H) and was not detected in +/+ B6 XX ovaries (G), as expected. Expression was not detected in Wt1+/2 and Sf1+/2 B6 XX ovaries (I and K). Ptch1 was
expressed in the central regions ofWt1+/2 (J) and Sf1+/2 (data not shown) B6 XYAKR ovotestes but at notably lower levels than in +/+ B6 XYAKR gonads,
and it was not expressed in Wt1+/2 (data not shown) and Sf1+/2 (L) XYAKR ovaries. Ptch1 expression was reduced in the anterior region of B6 Wt1+/2
mesonephroi (I and J), but not in Sf1+/2mesonephroi (K and L). The gonad/mesonephros complex in each panel is oriented with the gonad above the
mesonephros and separated by a dotted black line with the anterior (cranial) pole to the left. All images are at 106magnification.
doi:10.1371/journal.pgen.1002569.g002
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The Wt1 and Sf1 B6 alleles require additional interacting
genes to be homozygous for the B6 allele to function as
hypomorphs
The results presented above suggest that theWt1B6 and Sf1B6 alleles
are hypomorphic alleles. One possibility is that the Wt1B6 and Sf1B6
alleles behave as intrinsic hypomorphs. An alternative possibility is
that the Wt1B6 and Sf1B6 alleles function as hypomorphs only when
one or more additional interacting gene(s) are homozygous for B6
alleles. To distinguish between these two alternatives, genetic crosses
were designed that would generate hybrid (D26B6)F1 XYAKR mice
that are heterozygous for the null (knockout) allele of Wt1 or Sf1 and
the Wt1B6 or Sf1B6 allele, respectively (e.g. Wt1KO/Wt1B6 or Sf1KO/
Sf1B6 ) (Table 2). These F1 hybrid mice are genetically identical to
Wt1+/2 and Sf1+/2 B6 XYAKR mice at the Wt1 and Sf1 loci;
however, the remainder of the genome is different because it is
(D26B6)F1 hybrid (except for the regions immediately around the
Sf1KO andWt1KO alleles that are derived from the 129 strain). Because
Wt1+/2 and Sf1+/2 (D26B6)F1 XYAKR mice are not sex reversed,
we conclude that theWt1B6 and Sf1B6 alleles function as hypomorphs
only when other genes (modifier genes) are homozygous for B6 alleles.
Molecular analysis of the difference between the B6 and
D2 alleles of the Wt1 and Sf1 genes
The B6 and D2 alleles of the Wt1 and Sf1 genes could encode
different protein variants and/or have different expression
Table 3. Quantitative RT–PCR analyses of E12 +/2 versus +/+
B6 XYAKR gonads and E14 +/2 B6 XYAKR ovaries (ovotestes
excluded) versus +/+ B6 XYAKR testes.
Stage Gene Fold change in Wt1+/2 Significant (p,0.05)
E12 Bmp2 2.4 T
Cbln4 25.4 G, T
Dhh 26.0 G, T
Mro 26.0 G, T
Ptgds 211.82 G, T
Defb19 23.4 T
E14 Adamts19 10.7 G, T
Bmp2 10.7 G, T
Fgfr2 2.4 G
Fst 15.5 G, T
Sry 9.6 G, T
Wnt4 12.1 G, T
Aard 24.1 G, T
Amh 220.8 G, T
Cbln1 23.3 G, T
Cbln4 23.9 G, T
Col2a1 22.1 G
Col9a3 26.9 G, T
Cst9 25.1 G, T
Cyp11a1 24.7 G, T
Cyp17a1 28.2 G, T
Cyp26b1 24.0 G, T
Dhh 27.1 G, T
Etd 218.3 T
Hhip 24.1 G, T
Mro 22.1 G, T
Ptgds 28.0 G, T
Ren1 24.8 G, T
Sostdc1 24.7 G, T
Sox9 22.0 G, T
Defb19 28.6 G, T
Stage Gene Fold change in Sf1+/2 Significant (p,0.05)
E12 Bmp2 2.3 T
Sostdc1 2.4 G, T
Aard 29.9 G, T
Amh 219.9 G, T
Cbln4 27.3 G
Cst9 222.6 G, T
Dax1 22 T
Dhh 213.1 G, T
Hsdb1 21.9 T
Ptgds 212.7 G, T
Sf1 22.1 G
StAR 21.9 T
Sox9 22.3 G
Defb19 28.7 T
E14 Adamts19 6.8 G, T
Bmp2 7.2 G, T
Table 3. Cont.
Stage Gene Fold change in Sf1+/2 Significant (p,0.05)
Fgfr2 2.9 G
Fst 25.9 G, T
Sry 56.9 G, T
Wnt4 3.0 G
Aard 23.4 T
Amh 229.5 T
Cbln1 29.6 G, T
Cbln4 24.3 G, T
Col9a3 24.6 T
Cst9 27.3 T
Cyp11a1 266.9 T
Cyp17a1 289.9 T
Cyp26b1 28.3 T
Dhh 29.1 P = 0.06
Etd 222.3 G, T
Hhip 26.1 G, T
Hsdb1 214.7 G, T
Mro 22.4 G, T
Ptgds 215.4 G, T
Ren1 228.9 T
Scarb1 22.8 G, T
Sostdc1 28.2 G, T
Sox9 23.2 G, T
Defb19 218.5 G, T
Vnn1 22.6 G, T
G=GPR score equal or greater than 0.4.
T = Student’s t-test.
doi:10.1371/journal.pgen.1002569.t003
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patterns. A PCR primer-walking strategy using cDNA and
genomic DNA as template was employed to determine the DNA
sequence of the Wt1 and Sf1 genes present in the D2 genome and
these sequences were compared to the mouse B6 reference
sequence (data not shown). For Wt1, the ORF, 59 and 39 UTRs,
and about 1 kb of the upstream flanking region were sequenced.
One synonymous difference was identified in the ORF: a T (B6)
vs. C (D2) substitution at the third position of codon 339, which
was confirmed by its presence in dbSNP Build 128 (NCBI,
rs27444886). There were no differences in the 59 UTR and
upstream flanking region. Four differences were identified in the 39
UTR, two of which were confirmed by their presence in dbSNP
(rs33129887 and rs13467742). Two single base pair differences in
homopolymer length were not confirmed in dbSNP. The
functional significance, if any, of the 39 UTR polymorphisms is
not readily apparent.
For Sf1, the ORF, 59 and 39 UTRs, and ,1.5 kb of the
upstream and 500 bp of the downstream flanking regions were
sequenced. One synonymous and one non-synonymous difference
were identified in the ORF. The synonymous polymorphism was a
T (B6) vs. C (D2) substitution at the third position of the third
codon. This polymorphism is represented in dbSNP (rs3142930)
for certain inbred strains, but not for DBA/2J. The non-
synonymous polymorphism was a G (B6) vs. T (D2) substitution
in the first position of codon 172 resulting in an alanine (B6) vs.
serine (D2) amino acid substitution and was confirmed by its
presence in dbSNP (rs3142929). This polymorphism was inde-
pendently discovered by Frigeri and colleagues who first identified
it in ACTH resistant derivatives of the mouse Y1 adrenocortical
tumor cell line [41]. There were no differences in the 59 and 39
UTRs. The upstream and downstream regions each had one
difference, both in CA repeat units: The upstream CAAA repeat
had 6 units in B6 vs. 5 units in D2, while the downstream CA
repeat had 17 units in B6 vs. 22 units in D2. Neither
polymorphism is present in dbSNP and their functional signifi-
cance is not readily apparent.
To gain insight into whether the presence of the Sf1A172 (B6) vs.
Sf1S172 (D2) allele was correlated with B6 XY sex reversal, and
thus of potential functional significance, we took advantage of the
fact that when females from different inbred strains are mated to
B6 XYPOS hermaphrodites the F1 XY offspring are either sex
reversed or normal, and thus the inbred strains can be classified as
B6-like or D2-like, respectively (Table 6). Using this assay we
identified two strains (C57BL/10J and NZB/BlNJ) that are B6-like
and five strains (129S1/SvImJ, C3H/HeSnJ, SM/J C58/J and
BALB/cBy) that are D2-like. A PCR-RFLP genotyping assay that
was developed by Frigeri and colleagues [41] was used to
determine the strain distribution pattern of the Sf1A172 and
Sf1S172 alleles among these seven strains. As shown in Table 6, two
strains were phenotypically and genotypically discordant. NZB/
BlNJ was B6-like phenotypically but it has an Sf1S172 allele, and
BALB/cBy was D2-like phenotypically but it has an Sf1A172 allele.
We thus conclude that the presence of an Sf1A172 vs. Sf1S172 allele
alone is not strictly correlated with B6 XY sex reversal.
The Wt1 gene encodes multiple splice isoforms. Of particular
interest here, alternative splicing of exon nine gives rise to two
protein isoforms that differ by three amino acids and are referred
to as the +KTS and 2KTS isoforms. Both isoforms and their
correct relative expression are necessary for normal gonad
development [42]. For example, Frasier syndrome in humans is
associated with XY sex reversal and caused by reduced expression
of the Wt1 +KTS isoform [43]. Thus, it was possible that B6
XYAKR Wt1+/2 sex reversal could be caused by altered +KTS/
2KTS isoform ratios and qRT-PCR using primers that span the
exon nine splice junction was employed to examine if the ratio of
+KTS/2KTS splice isoforms is different in E10.5–14.5 B6 vs. D2
XX and XY gonad/mesonephros complexes. We found that the
relative expression of the Wt1 +KTS and 2KTS isoforms did not
differ between B6 and D2 gonad/mesonephros complexes (data
not shown).
To test the hypothesis that the Wt1B6 and Sf1B6 alleles function
as hypomorphs because they are expressed at lower levels or with
different temporal profiles than the Wt1D2 and Sf1D2 alleles,
respectively, transcript levels in B6 vs. D2 XY gonad/mesoneph-
ros complexes from E10.5–13.5 fetuses were quantified using
qRT-PCR (Figure 5). Wt1 expression was significantly lower in B6
vs. D2 samples at all stages. Sf1 expression also was lower in B6 vs.
D2 gonad/mesonephros complexes from E11.0–12.0 fetuses, but
these differences were not statistically significant. These Wt1 and
Sf1 expression results were corroborated in XX samples from
similar stages, and the Sf1 expression results were further
confirmed by using an independent SYBR green qRT-PCR assay
to analyze a subset of the samples (data not shown). In summary,
these molecular analyses suggest thatWt1B6 is a hypomorph due to
reduced expression and that Sf1B6 is a hypomorph possibly due to
altered protein structure and/or the presence of other modifier B6
loci.
Reducing Wnt4 dosage increases the amount of testis
tissue that develops in multiple cases of B6 XY sex
reversal
To examine the possibility that Wnt4 would be haploinsufficient
on the B6 genetic background and to investigate its candidacy as a
tda gene, we transferred a Wnt4 null allele onto the B6 genetic
background and assessed if Wnt4 heterozygosity exacerbated XY
sex reversal in B6 XYPOS, B6 XYAKR, Sf1+/2 B6 XYAKR, and
Wt1+/2 B6 XYAKR fetuses. WIHC was used to examine gonad
morphology and marker gene expression at E13.5. Each gonad/
mesonephros complex was assessed at dissection for the presence
of cords and male-specific vasculature, and classified as an ovary,
ovotestis, or testis (Table 7). Classification was done prior to
Table 4. Survival of Wt1+/2; Sf1+/2 offspring.
Offspring genotypes
Stage
Maternal
genotype
Paternal
Genotype
Sf1+/+;
Wt1+/+
Sf1+/+;
Wt1+/2
Sf1+/2;
Wt1+/+
Sf1+/2;
Wt1+/2 Total
Weaning B6 Wt1+/2 B6 Sf1+/2 43 34 7 0 84
B6 Wt1+/2 D2 Sf1+/2 3 4 2 3 12
E14.5–15.5 B6 Wt1+/2 B6 Sf1+/2 6 3 10 4 23
doi:10.1371/journal.pgen.1002569.t004
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ascertainment of the fetal genotype and was done by a single
investigator (SMC) for consistency. A subset of complexes of each
genotype was processed for WIHC and examined by two
investigators (SMC and KHA) to confirm the initial classification
(Figure 6). In all four experimental groups, reducing Wnt4 dosage
increased the area containing testicular cords and reduced the area
without obvious structure in XY gonads. In B6 XYPOS fetuses, 5 of
the 12 gonads analyzed from Wnt4+/+ fetuses were classified as
ovaries and none were classified as testes, whereas 7 of the 28
gonads analyzed from Wnt4+/2 fetuses were classified as ovaries
and 4 were classified as testes. These data indicate that reducing
Wnt4 dosage in B6 XYPOS fetuses decreased the percentage of
ovaries from 42% to 25% and increased the percentage of testes
from 0% to 14%. In B6 XYAKR fetuses, 12 of the 16 gonads
analyzed from Wnt4+/+ fetuses were classified as ovotestes and 4
were classified as testes, whereas 6 of the 18 gonads analyzed from
Wnt4+/2fetuses were classified as ovotestes and 12 were classified
as testes. Thus, reducing Wnt4 dosage in B6 XYAKR mice
decreased the percentage of ovotestes from 75% to 33% and
increased the percentage of testes from 25% to 67%. In B6Wt1+/2
XYAKR fetuses, 3 of the 12 gonads analyzed from Wnt4+/+ fetuses
were classified as ovaries, 5 as ovotestes, and 4 as testes, whereas
none of the 6 gonads analyzed inWnt4+/2 fetuses were classified as
ovaries, 1 was an ovotestis and 5 were testes. Thus, reducing Wnt4
dosage in Wt1+/2 B6 XYAKR mice decreased the percentage of
ovaries from 25% to 0%, decreased the percentage of ovotestes from
42% to 17%, and increased the percentage of testes from 33% to
83%. In Sf1+/2 B6 XYAKR fetuses, all 8 gonads analyzed
from Wnt4+/+ fetuses were classified as ovaries, whereas 2 of the
12 gonads analyzed from Wnt4+/2 fetuses were classified as
ovaries, 3 as ovotestes, and 7 as testes. Thus reducing Wnt4 dosage
in B6 Sf1+/2 XYAKR mice decreased the percentage of ovaries
from 100% to 17%, increased the percentage of ovotestes from 0%
to 25%, and increased the percentage of testes from 0% to 58%.
The WIHC analyses confirmed these results (Figure 6).
These data indicate that Wnt4B6 acts like an anti-testis gene.
Using qRT-PCR we found that Sry expression in Wnt4+/+ vs.
Wnt4+/2 B6 XYAKR was not significantly different during peak
Sry expression in E11.75 (21–23 ts) gonad/mesonephros complex-
es (data not shown), suggesting that Wnt4B6 compromises the testis
pathway downstream of Sry [36]. Together, these data suggest that
Wnt4B6 behaves as a hypermorphic allele of a gene in the ovary
determination pathway, rather than a hypomorphic allele of a
gene in the testis determination pathway.
Elevated expression of ovary-biased genes in B6 versus
D2 XX ovaries
The Wnt4 results presented above suggested the possibility that
the ovary differentiation pathway is prematurely- or hyper-
activated in B6 gonads, thereby suppressing the testis determina-
tion pathway. As with Wt1 and Sf1, the B6 and D2 Wnt4 alleles
could encode different protein variants or have different
expression patterns. We determined the DNA sequence of the
Wnt4 ORF present in the D2 genome and found that it did not
differ from that in B6, which was confirmed by data present in
dbSNP Build 128 (data not shown). We used qRT-PCR to
compare the expression of Wnt4 and seven other genes in the
ovary differentiation pathway in E12.5 B6 vs. D2 XX ovaries to
test the hypothesis that Wnt4B6 is an expression hypermorph and
to investigate the possibility that the ovary differentiation pathway
is prematurely- or hyper-activated in B6 gonads (Figure 7). The
seven genes were chosen because their expression normally is
ovary-biased at E12.5 (i.e., their expression is either ovary-specific
or higher in ovaries vs. testes) [34,38,44–46]. We found that the
expression of Wnt4 (p,0.0004), Adamts19 (p,0.026), Fst
(p,0.0001), Igfbp2 (p,0.0001), and 1700106J16Rik (p,0.0001)
was significantly higher in B6 vs. D2 ovaries; that expression of
Irx3 (p,0.177) and Bmp2 (p,0.323) was not significantly different;
and that expression of Rspo1 (p,0.0002) was significantly lower.
These results demonstrate that Wnt4 and other genes known, or
thought to be, in the ovary differentiation pathway are
hyperactivated in E12.5 B6 vs. D2 XX gonads.
Discussion
It has been suggested that some genetic events leading to testis
determination differ between humans and mice because several
genes that are haploinsufficient in humans appeared to be
haplosufficient in mice [18]. However, based on our studies of
B6-YPOS sex reversal we hypothesized that genetic background
would have a significant influence and that some of these genes
would be haploinsufficient on the B6 genetic background. We
chose to analyze the Wt1, Sf1, and Wnt4 genes for two main
reasons: 1) they are dosage-sensitive in humans but initial studies
suggested they were dosage-insensitive in mice, and 2) they are
good candidates for tda genes based on genetic location and
because gonad differentiation is abnormal in homozygous
knockout mice. Our analyses show that these three genes can be
dosage-sensitive in mice, depending on the genetic background,
and provide insights into the mechanisms of B6 XY sex reversal.
The Wt1 and Sf1 genes are dosage-sensitive on the B6
genetic background
Our results show that the Wt1 and Sf1 B6 alleles are
haploinsufficient for normal testis differentiation when present
on the B6 genetic background. We found thatWt1+/2 and Sf1+/2
B6 XYB6 mice developed as males; however, testis differentiation
was transiently delayed and was further compromised in double
heterozygous Wt1+/2; Sf1+/2 B6 XYB6 fetuses. These data are
consistent with evidence that Wt1 activates Sf1 transcription [30].
When the genetic background was further sensitized by substituting
the YB6 Chr with the YAKR Chr, testis differentiation was
more severely affected and Wt1+/2 and Sf1+/2 B6 XYAKR
mice developed ovotestes and ovaries. In contrast, all Wt1+/2 and
Sf1+/2 (D26B6)F1 XYAKR mice developed testes. Taken together,
these results show that the Wt1 and Sf1 B6 alleles are hypomorphic
Figure 3. Histological and WIHC analysis ofWt1+/2; Sf1+/2 B6 XYB6 fetuses. (A and B, 106magnification) Hematoxylin and eosin staining of
E14.5–15.5 fetal sagittal sections showed the absence of adrenal glands in Wt1+/2; Sf1+/2 B6 XYB6 and XX (data not shown) fetuses. The inset panels
in A and B are a magnified view showing that normal testicular cords were present in bothWt1+/+; Sf1+/+ andWt1+/2; Sf1+/2 B6 XYB6 fetuses (white
dotted line outlines a section of a single cord). (C–J) WIHC analysis of E13.5 B6 XYB6 gonad/mesonephros complexes stained with SOX9 (Sertoli cells,
green) and PECAM (germ cells and vascular endothelial cells, red). Panels C, E, G and I show 106 images taken with 0.76zoom. Panels D, F, H, and J
show 206 images. The gonads in all wild-type and single heterozygous E13.5 B6 XYB6 gonads were classified as testes, but testis cords in Wt1+/2;
Sf1+/+ (E and F) andWt1+/+; Sf1+/2 (G and H), B6 XYB6 gonads were less developed and more disorganized than cords inWt1+/+; Sf1+/+ (C and D) B6
XYB6 gonads. B6 Wt1+/2; Sf1+/+ gonads, however, were more similar to wild-type gonads than were Wt1+/+; Sf1+/2 gonads. Testis differentiation
was most affected in Wt1+/2; Sf1+/2 B6 XYB6 gonads and these were classified as ovotestes: Sertoli cells in the anterior and posterior poles often
expressed SOX9 but were not organized into cords (I and J).
doi:10.1371/journal.pgen.1002569.g003
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relative to the D2 alleles. Analysis of morphology and marker gene
expression in E13.5 Wt1+/2 and Sf1+/2 B6 XYAKR gonads
showed that some developed as ovaries and were indistinguishable
from control XX ovaries in that they expressed ovary-specific
markers, and did not express Sertoli cell or Leydig cell-specific
markers. These data indicate that the testis-determining pathway is
interrupted at a very early stage in these XY gonads.
In addition to defects in testis differentiation, we found that
double heterozygous Wt1+/2; Sf1+/2 fetuses lacked adrenal
glands and that neonates die shortly after birth, presumably from
adrenal insufficiency. Because the gonads and adrenal cortex share a
common origin [47], because the morphological defects we observed
occur early in the development of these organs, and because the
lethality and sex reversal phenotypes were sensitive to genetic
background in a similar way, we hypothesize that the initial defect
occurs during the adrenogonadal progenitor stage and that one or
more tda gene(s) plays a role in the differentiation of this progenitor
into the adrenal cortex and gonads. While it has been known that
Wt1, Sf1 and Wnt4 are necessary for adrenal cortex differentiation
[14–17,34,35,48], our results show that Wt1 and Sf1 interact
genetically during adrenal development. These results are consistent
with results reported for fetuses that are double heterozygous for Sf1
and Cited2, a transcription cofactor that interacts with Wt1 [49].
Given thatWt1 is thought to directly activate Sf1 transcription in the
gonadal progenitor, our results suggest that this genetic pathway is
important for the differentiation of the adrenogonadal progenitor. It
will be interesting to determine how Wnt4 fits into this genetic
pathway in the adrenogonadal progenitor.
Wt1 and Sf1 regulate Sry expression, but reduced Sry
transcript levels are not solely responsible for sex reversal
in Wt1+/2 or Sf1+/2 B6 XY mice
Consistent with these indications of an early defect in testis
differentiation, we found that Sry expression was markedly
reduced in heterozygous mutant gonads. Our unpublished data
indicate that reduced expression results from both a direct effect
on Sry expression and an indirect effect on the differentiation of
pre-Sertoli cells (manuscript in preparation). Interestingly,
increasing Sry dosage by replacing the YAKR Chr in Wt1+/2
or Sf1+/2 B6 XYAKR fetuses with the YAKR,Sxr Chr dramatically
increased the amount of testis tissue that developed but cord
differentiation remained somewhat abnormal. Our previous
experiments showed that the SryAKR and SrySxr alleles are
expressed with similar profiles and at similar levels in gonads
from B6 XYAKR,Sxr fetuses [29], suggesting that Sry expression is
essentially doubled in these gonads. Thus, testicular cord
differentiation was compromised in Wt1 and Sf1 heterozygotes,
regardless of Sry dosage. These results suggest that reduced Sry
transcript levels are not the sole cause of sex reversal in Wt1+/2
and Sf1+/2 B6 XYAKR mice and that the expression of critical
genes other than Sry is likely to be affected. We consistently found
that the Sf1 heterozygous phenotype was more severe than the
Wt1 heterozygous phenotype. However, the reduction in Sry
expression was not statistically different between the two
heterozygotes, which supports our hypothesis that genes and
cellular processes other than those controlled by SRY contribute
to the phenotypic differences. Our result agree with previous
reports suggesting that Sry expression levels alone do not predict
whether a given Y Chr causes testis differentiation defects on the
B6 genetic background [50] and that sex reversal is caused by
both the presence of particular SRY protein isoforms found in M.
domesticus mice and reduced Sry expression [29].
Analysis of Wt1 and Sf1 heterozygous gonads identifies
potential downstream targets
The analysis of marker gene expression using WISH provided
insights into potential Wt1 and Sf1 target genes. For example,
Wnt4 expression was reduced in Wt1+/2 and Sf1+/2 B6 XX
ovaries compared to +/+ B6 XX ovaries indicating that Wt1 and
Sf1 might regulate Wnt4 expression in ovaries (Figure 2). In
Figure 4. Sry expression is reduced in Wt1+/2 and Sf1+/2 B6 XYAKR gonads, but increased Sry dosage did not fully restore normal
cord differentiation. (A) Real-time qRT-PCR analysis of Sry expression relative to Gapdh (22DCt) showing mean Sry transcript levels +/2 standard
error. The sample size for each group is shown adjacent to the corresponding data point. An asterisk denotes statistically significant effects of
genotype (ANOVA, a=0.05). There was a marginally significant effect of genotype at E11.25 (15–17 ts, ANOVA, F2,28 = 3.1670, p,0.0576) and a
significant effect of genotype at E11.5 (18–20 ts, ANOVA, F2,34 = 6.999, p,0.0028) and E11.75 (21–23 ts, ANOVA, F2,7 = 15.41, p,0.0027). Pairwise
comparisons revealed a significant reduction in Sry transcript levels in Wt1+/2 vs. +/+ samples at E11.25 (15–17 ts, t24 = 2.224 , p,0.0179), E11.5 (18–
20 ts, t25 = 3.653, p,0.0012), and in E11.75 (21–23 ts, t3 = 11.51, p,0.0014). Similarly, Sry expression was reduced in Sf1+/2 vs. +/+ samples at E11.5
(18–20 ts, t29 = 2.125, p,0.0422) and E11.75 (21–23 ts, t5 = 6.142, p,0.0016). (B) The amount of tissue expressing the Sertoli cell marker AMH (green)
was greater in Wt1+/2 and Sf1+/2 B6 XYAKR,Sxr gonads (E and F), which have two copies of the Sry gene, compared to Wt1+/2 and Sf1+/2 B6 XYAKR
gonads (B and C), which have the normal single copy of the Sry gene (top two rows, 106magnification with 0.76zoom). However, whileWt1+/2 and
Sf1+/2 B6 XYAKR,Sxr gonads developed more testicular tissue than Wt1+/2 and Sf1+/2 B6 XYAKR gonads, they consistently develop less testicular
tissue than +/+ B6 XYAKR,Sxr controls. Additionally, cords were less differentiated and less organized in heterozygous mutants when compared to wild-
type B6 XYAKR,Sxr gonads, even in the central regions of the gonads where cord differentiation was most complete (G–I, bottom row, 206
magnification). Germ and vascular endothelial cells are labeled by PECAM staining (red).
doi:10.1371/journal.pgen.1002569.g004
Table 5. Increasing Sry dosage partially rescues the sex reversal phenotypes of E13.5 B6 XYAKR, Wt1+/2 B6 XYAKR, and Sf1+/2
B6XYAKR gonads.
Genotype examined Ovaries Ovotestes Abnormal testes Testes Total gonads
B6 Wt1+/2 XYAKR 3 (25%) 7 (58%) 2 (17%) 0 (0%) 12
B6 Wt1+/2 XYAKR,Sxr 0 (0%) 1 (13%) 7 (88%) 0 (0%) 8
B6 Sf1+/2 XYAKR 21 (95%) 1 (5%) 0 (0%) 0 (0%) 22
B6 Sf1+/2 XYAKR,Sxr 0 (0%) 5 (63%) 3 (38%) 0 (0%) 8
B6 +/+ XYAKR,Sxr 0 (0%) 0 (0%) 0 (0%) 17 (100%) 17
doi:10.1371/journal.pgen.1002569.t005
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contrast, Wnt4 expression was elevated in Wt1+/2 and Sf1+/2
B6 XYAKR gonads compared to +/+ gonads, but we suspect that
this increase is due to the presence of more ovarian tissue in these
gonads. Expression of Wnt4 also was reduced in Wt1+/2 XX and
XY mesonephroi. Because Sf1 is not expressed in mesonephroi,
reduced Wnt4 expression indicates in this tissue WT1 regulates
Wnt4 expression independently of SF1. Ptch1 expression also was
reduced in Wt1+/2 XX and XY mesonephroi. Interestingly,
Ptch1 is strongly expressed in the region where the mesonephric
tubules form and the number of tubules is reduced in Wt12/2
mesonephroi [14]. This result suggests that Wt1 regulates Ptch1
expression and that Ptch1 could have a role in the formation of
mesonephric tubules. However, these WISH results, though quite
intriguing, require confirmation with a more quantitative method
such as qRT-PCR.
Co-expression of ovarian and testicular markers suggests
reduced antagonism of the ovary and testis
differentiation pathways in B6 XY gonads
Analysis of E13.5 B6 XYAKR gonads showed that the anterior
and posterior regions that lacked testicular cords expressed
multiple ovarian somatic cell markers and that the germ cells
within these domains had initiated meiosis. Therefore, these
regions were not simply undifferentiated, but rather had
initiated the ovary differentiation program in both somatic
and germ cells. By E15.5, testicular cords are present
throughout B6 XYAKR gonads and it is unclear what happens
to the ovarian regions between these two stages. Two
possibilities are that these ovarian cells might transdifferentiate
into the analogous testicular cell types, or regress via apoptosis.
A recent analysis showed that the ovarian regions in Sox9
Table 6. Strain distribution pattern of the Sf1A172 versus
Sf1S172 alleles.
Inbred strain F1 phenotype NcoI genotype rs3142929 confirmed
C57BL/6J B6-like + +
C57BL/10J B6-like + 2*
NZB/BlNJ B6-like 2 +
DBA/2J D2-like 2 +
129S1/SvImJ D2-like 2 +
C3H/HeSnJ D2-like 2 not available
SM/J D2-like 2 +
C58/J D2-like 2 +*
BALB/cBy D2-like + +
*Indicates an imputed value.
doi:10.1371/journal.pgen.1002569.t006
Figure 5.Wt1 but not Sf1 transcript levels were significantly lower in B6 versus D2 gonad/mesonephros complexes. Real-time qRT-PCR
analysis of Wt1 and Sf1 expression normalized to Gapdh (22DCt) showing mean transcript levels +/2 standard error. Wt1 and Sf1 expression were
determined in the same B6 and D2 samples, therefore the samples sizes are only shown above the corresponding error bars for the Wt1B6 and Wt1D2
comparisons. An asterisk denotes statistically significant differences in pairwise comparisons (a= 0.05). Wt1 expression was significantly lower in B6
vs. D2 samples at E10.5 (10–13 ts, t15 = 2.063, p,0.0284), E11.0 (14–17 ts, t40 = 5.355, p,0.00002), E11.5 (18–21 ts, t29 = 1.699, p,0.0500), E12.5 (27–
30 ts, t10 = 3.441, p,0.0032), and E13.5 (t12 = 5.985, p,0.0003). Wt1 expression also was lower in B6 than in D2 samples at E12.0 (27–30 ts) but the
difference did not reach statistical significance (t13 = 1.741, p,0.0526). Sf1 expression was lower in B6 vs. D2 gonad/mesonephros complexes at E11.0
(t40 = 1.466, p,0.0753), E11.5 (t29 = 1.182, p,0.1235), and E12.0 (t13 = 1.208, p,0.1243), but these differences were not statistically significant.
doi:10.1371/journal.pgen.1002569.g005
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transgenic XX ovotestes regress via apoptosis [51] and our
preliminary analyses suggest that there is an increased number
of apoptotic cells within the ovarian regions in B6 XYAKR
ovotestes (data not shown). In these regions it was clear that
most cells expressed either ovarian (FOXL2) or testicular
(AMH) markers and that these cells could be interspersed. We
propose that co-expression of ovarian and testicular markers in
E13.5 B6 XY ovotestes suggests that antagonism between these
opposing differentiation pathways is reduced in these XY
gonads. Contrary to results reported by Bradford and colleagues
[52], we did observe a few cells at the boundaries between
testicular and ovarian domains that appeared to express both
granulosa and Sertoli cell markers. We could not unequivocally
demonstrate co-expression using the markers and techniques
presented here, however, the possibility that cells expressing
both female and male supporting cell progenitor markers might
be present during fetal gonad differentiation warrants further
investigation.
Table 7. Reducing the Wnt4 dosage partially rescues the sex reversal phenotypes of E13.5 B6 XYPOS, B6 XYAKR, B6 Wt1+/2 XYAKR,
and B6 Sf1+/2 XYAKR gonads.
E13.5 XY gonad phenotype
Maternal
genotype
Paternal
genotype Fetal genotype Ovaries Ovotestes Testes Total gonads
B6 Wnt4+/2 B6 XYPOS B6 Wnt4+/+ XYPOS 5 (42%) 7 (58%) 0 (0%) 12
B6 Wnt4+/2 XYPOS 7 (25%) 17 (61%) 4 (14%) 28
B6 Wnt4+/2 B6 XYAKR B6 Wnt4+/+ XYAKR 0 (0%) 12 (75%) 4 (25%) 16
B6 Wnt4+/2 XYAKR 0 (0%) 6 (33%) 12 (67%) 18
B6 Wt1+/2 B6 Wnt4+/2 XYAKR B6 Wt1+/2; Wnt4+/+ XYAKR 3 (25%) 5 (42%) 4 (33%) 12
B6 Wt1+/2; Wnt4+/2 XYAKR 0 (0%) 1 (17%) 5 (83%) 6
B6 Sf1+/2 B6 Wnt4+/2 XYAKR B6 Sf1+/2; Wnt4+/+ XYAKR 8 (100%) 0 (0%) 0 (0%) 8
B6 Sf1+/2; Wnt4+/2 XYAKR 2 (17%) 3 (25%) 7 (58%) 12
doi:10.1371/journal.pgen.1002569.t007
Figure 6. Reduced Wnt4 dosage partially rescued cord differentiation in B6 XY genotypes that typically develop ovarian tissue.
Representative images are shown for Wt1+/2 (A and B) and Sf1+/2 (C and D) B6 XYAKR E13.5 gonads that were either Wnt4+/+ (A and C) or Wnt4+/2
(B and D). The amount of tissue expressing the Sertoli cell marker AMH (green) was consistently greater in Wnt4+/2 vs. Wnt4+/+ gonads for all four
sex reversals examined. Germ and vascular endothelial cells are labeled by PECAM staining (red).
doi:10.1371/journal.pgen.1002569.g006
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Why are the Wt1 and Sf1 B6 alleles haploinsufficient?
To determine why the Wt1B6 and Sf1B6 alleles are haploinsuffi-
cient and function as hypomorphs, we compared the coding
sequences and expression levels of the B6 and D2 alleles. The
results indicated that the Wt1B6 and Wt1D2 allele encode the same
protein and that the 6KTS Wt1 isoform expression ratio was the
same in B6 and D2 gonad/mesonephros complexes. However, we
found that Wt1 expression throughout the initial stage of testis
differentiation was lower in complexes from B6 fetuses, suggesting
that in the B6 genetic background theWt1B6 allele is an expression
hypomorph. In contrast, we were unable to detect significantly
lower Sf1 expression in complexes from B6 fetuses but we did
identify one coding polymorphism in Sf1, suggesting that the Sf1B6
allele is haploinsufficient not because its expression is reduced but
possibly because the SF1B6 protein variant has reduced function. It
appears that two SF1 variants are present among the common
inbred mouse strains: SF1A172 (present in B6) and SF1S172 (present
in D2). However, we found that homozygosity for the Sf1A172 allele
in F1 hybrids was not sufficient to cause sex reversal in the
presence of the YPOS Chr [as in (NZB/BlNJ6B6 XYPOS) F1s] and
that trans-heterozygosity for the Sf1A172 and Sf1S172 alleles was not
sufficient to prevent sex reversal in the presence of the YPOS Chr
[as in (BALB/cBy6B6 XYPOS) F1s]. These data show that the
SF1A172 polymorphism alone does not account for sex reversal in
the presence of the YPOS Chr. Therefore, if the SF1A172 protein
variant does indeed have reduced function during testis determi-
nation, then homozygosity for B6 alleles at other loci likely is
necessary to cause Sf1B6 to function as a hypomorph. Frigeri and
colleagues [41] demonstrated that the SF1A172 and SF1S172
protein variants did not consistently differ in their ability to
transactivate reporter genes containing tandem SF1 binding sites,
in vitro. However, further experiments are needed to determine if
the SF1A172 protein variant has reduced function during gonad
differentiation in vivo.
The Wnt4 B6 allele is dosage-sensitive in the B6 genetic
background and may contribute to hyperactivation of
the ovary differentiation pathway
Our genetic results suggest that the Wnt4B6 allele functions as a
hypermorph in the ovary determination pathway. To ascertain if
the ovary determination pathway was hyperactive in B6 vs. D2
gonads we quantified the expression of eight ovary-biased or
ovary-specific genes in E12.5 B6 vs. D2 XX ovaries. We chose this
developmental stage because existing data suggested that the ovary
pathway would be active and that the chosen markers would be
expressed at detectable levels. We chose to analyze XX and not
XY gonads because an increase in ovary gene expression in XY
gonads could be caused by failure to activate the testis pathway
and subsequent failure to suppress the ovary pathway. We found
that the expression of Wnt4, and four other genes was higher in B6
ovaries, indicating that the ovary determination pathway is
activated earlier and/or to a greater degree in B6 vs. D2 ovaries.
These results are consistent with those reported in an eQTL study
of B6 vs. 129 gonads [53]. The B6 vs. D2 expression differences do
not appear to be caused by gross differences in development
between these two strains because we did not detect differences in
Figure 7. Real-time qRT–PCR analysis of ovarian marker gene expression in B6 versus D2 E12.5 XX gonads. Expression of ovary-specific
genes Wnt4, Adamts19, Fst, Ifgbp2, 1700106J16Rik, Irx3, Bmp2, and Rspo1 were measured in the same samples and normalized to Hprt (D2, n = 6
gonad/mesonephros complexes; B6, n = 10 gonad/mesonephros complexes). Fold change relative to mean D2 values was determined using the
22DDCt method and plotted as the average per sample group +/2 standard error. An asterisk denotes statistically significant differences in pairwise
comparisons (a=0.05). The expression levels of Wnt4 (t14 = 1.938, p,0.0365), Adamts19 (t14 = 2.13, p,0.0257), Fst (t14 = 4.865, p,0.0001), Ifgbp2
(t14 = 4.987, p,0.0001), and 1700106J16Rik (t14 = 5.002, p,0.0001) were significantly higher in B6 vs. D2 XX ovaries. Expression of Irx3 and Bmp2 did
not significantly differ between the two strains, and Rspo1 expression was significantly lower in B6 vs. D2 XX ovaries (t14 = 4.612, p,0.0002).
doi:10.1371/journal.pgen.1002569.g007
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limb morphology or in the size of the gonads or mesonephroi at
the 27–28 ts stage used for these analyses (data not shown).
However, not all eight genes were up-regulated in B6 ovaries: two
were not significantly different, and one was down-regulated. We
find it intriguing that Rspo1, which maps close to Wnt4 within the
tda1 region, had reduced expression in B6 ovaries. However,
because the Rspo1 and Wnt4 knockout phenotypes are very similar
in that ovary and not testis differentiation is primarily affected, and
because Wnt4 expression is greatly reduced in Rspo12/2 XX
gonads [54,55], we think it is unlikely that Rspo1 is tda1 because we
would expect that a strain with reduced Rspo1 expression like B6
would be less sensitive to XY sex reversal, whereas B6 is, in fact,
more sensitive. We note that for Rspo1 no SNPs that differ between
the B6 and D2 strains are present in dbSNP (Build 128), indicating
that the RSPO1 protein does not differ between these strains.
Furthermore, we suggest that the interaction between Rspo1 and
Wnt4 may be indirect because Rspo1 expression in decreased in B6
mice while Wnt4 expression is increased. Nevertheless, these data
do not formally exclude Rspo1 as a tda1 candidate.
Are Wt1, Sf1, and Wnt4 tda genes?
More than twenty-five years ago, two of the authors
hypothesized that the B6-derived tda genes could function later
than normal in the testis determination pathway and/or, because
the testis and ovary determination pathways antagonize each
other, could function earlier than normal in the ovary determi-
nation pathway [25,56]. Thus, if a tda gene functions in the testis-
determining pathway, then reducing its dosage in B6 XY mice
should cause sex reversal, whereas reducing its dosage in D2 XY
mice should not. Similarly, if a tda gene functions in the ovary-
determining pathway and antagonizes testis differentiation, then
reducing its dosage should ameliorate B6 XY sex reversal. The
Wt1 and Sf1 genes fulfill the criteria as late functioning testis-
determining genes andWnt4 fulfills the criteria as an early function
ovary-determining gene that antagonizes testis differentiation.
Furthermore, our results show that B6 XYPOS, Wt1+/2 B6
XYAKR, and Sf1+/2 B6 XYAKR sex reversal share similar
gonadal phenotypes and that these three sex reversals are sensitive
to genetic background in a similar way. Additionally, we have
recently determined that a major modifier of Sf1+/2 B6 XYAKR
sex reversal that differs between the B6 and D2 genomes, maps to
the distal region of Chr 4, which suggests that the tda1 modifier
gene plays a prominent role in both Sf1+/2 B6 XYAKR and B6
XYPOS sex reversal (manuscript in preparation). However, while
our data are consistent with the hypothesis that tda2 is comprised
of Wt1 and Sf1 and that tda1 is Wnt4, the genetic intervals defined
by the linkage analyses are fairly broad, and further experiments
are needed to directly test this hypothesis and to exclude the
possibility of other candidate genes in the tda1 and tda2 intervals.
Undoubtedly, tda genes in addition to tda1 and tda2 contribute
to B6 XYPOS sex reversal because, as shown in the original linkage
analysis, some XYPOS fetuses that were homozygous for B6 alleles
at the tda1 and tda2 loci contained normal appearing testes [24].
Nevertheless, it appears that tda1 and tda2 play an important role
in many cases of B6 XY sex reversal because we have mapped a
major modifier of Dax1 2/Y sex reversal that differs between the
B6 and D2 genomes to the same chromosome region as tda1 [22],
and have recently determined that major modifiers of Gata4 +/2
B6 XYAKR sex reversal [23] map to the same chromosome regions
as tda1 and tda2 (manuscript in preparation).
An additive model to explain B6 XY sex reversal
Overall, our data suggest that the B6 inbred strain is sensitive to
XY sex reversal, at least in part, due to hypomorphic alleles ofWt1
and/or Sf1 that compromise the testis determination pathway, as
well as a hypermorphic allele of Wnt4 that antagonizes testis
development. We suggest that in XY gonads of most inbred
strains, such as DBA/2J, the testis determination pathway reaches
a critical threshold that is sufficient to inactivate the ovary
determination pathway prior to the developmental stage when the
ovary determination pathway reaches a threshold that is sufficient
to inactivate the testis determination pathway. In contrast, in a few
inbred strains such as B6, the testis determination pathway is
compromised and the ovary determination pathway is hyperacti-
vated, thus the interval between the developmental stages at which
these two thresholds are reached is greatly reduced. We propose
that this interval is even further reduced or eliminated in B6 mice
carrying certain M. domesticus-derived Sry alleles that do not
efficiently activate the testis determination pathway, thus allowing
ovotestes to develop transiently in B6 XYAKR mice and allowing
stable ovotestes and ovaries to develop in B6 XYPOS mice, for
example. In summary, we propose that sex reversal in B6 XYPOS
gonads is the result of the additive effects of 1) hypomorphicWt1B6
and/or Sf1B6 alleles, 2) a hypermorphic Wnt4B6 allele and
hyperactivation of the ovary pathway, 3) reduced function of M.
domesticus-derived SRY proteins, 4) reduced expression of the
SryPOS allele, and 5) the presence of other unidentified tda genes.
Mouse models of human dosage-sensitive sex reversal
These studies demonstrate that Wt1, Sf1, and Wnt4 are dosage-
sensitive in mice, as they are in humans, and show that this effect is
modulated by genetic background, as we suspect it is in humans.
They also demonstrate that the Wt1+/2 and Sf1+/2 B6-YAKR
mice are good models for the corresponding human XY sex
reversals involving heterozygous mutations in these genes. We
suggest that these heterozygous mice will be very useful for the
elucidation of Wt1 and Sf1 functions during gonad differentiation
because the heterozygous phenotype is far less severe than the
homozygous phenotype, which is a complete abrogation of gonad
differentiation and subsequent apoptosis at the genital ridge stage.
Thus, we think it is likely that these strains will be particularly
useful in providing further insights into the roles of Wt1 and Sf1 in
organogenesis and human disease.
Materials and Methods
Animals and genotyping
Null (knockout) alleles of Wt1 (Wt1tm1Jae) [14], Sf1 (Nr5a1tm1Klp)
[16], andWnt4 (Wnt4tm1Amc) [34] were transferred to the B6 and D2
inbred strain backgrounds using standard backcrossing. No sex ratio
disturbances were noted in heterozygous progeny during construc-
tion of these congenic strains. Experimental results reported here
were conducted after backcross generation N10 or greater was
achieved. The B6-YPOS, B6-YAKR, B6-YAKR,Sxr and D2-YAKR
consomic strains were previously described [19,20,23,29,57]. This
study was carried out in strict accordance with the recommenda-
tions in the Guide for the Care and Use of Laboratory Animals of
the National Institutes of Health. The Jackson Laboratory and
Boston University Laboratory Animal Science Center are AALAS
accredited and all animal procedures were approved by The
Jackson Laboratory Animal Care and Use Committee (protocols
LAH:93-26, LAH:95-01, LAH:95-02) or the Boston University
Animal Care and Use Committee (protocol AN-13935).
The presence of a Wt1, Sf1, or Wnt4 knockout allele was
determined by multiplex PCR using primers to detect the
neomycin cassette and the myogenin gene as a control [23]. In
crosses involving multiple knockout alleles, gene-specific PCR
assays were used to amplify both the normal and the targeted
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alleles [46,58]. The genetic sex of fetuses was determined by PCR
using Y Chr specific primers and myogenin control primers [59].
The B6-YAKR,Sxr strain carries a rearranged Y Chr containing two
Sry alleles: the M. domesticus-derived SryAKR allele and the M.
musculus-derived SrySxr allele. The presence of the M. domesticus
and/or M. musculus Sry alleles was determined by PCR followed by
digestion with NlaIV restriction enzyme using primers that flank a
polymorphism within the Sry gene [29].
Embryo isolation and staging, and determination of
sexual phenotype
Timed matings were used for all embryonic experiments. Noon
on the day of vaginal plug detection was designated as E0.5.
Embryos between E10.5 and 12.5 were precisely staged by counting
the number of tail somites (E10.5,8 ts, E11.5,18 ts, E12.5,30 ts)
[60] and those between E12.5 and E16 were staged by limb
morphology and the extent of cranial vessel formation [61].
To classify the gonads of individual E14.5–16 fetuses, the gonads
were removed from the body cavity and immediately examined with
the aid of an inverted microscope using transmitted light, and then
photographed [62]. Testes were identified as having distinctive cords
and vasculature, and an incipient tunica albuginea. Ovaries were
identified as having a reticular appearance and lacking the structures
noted above in the testes. Ovotestes contained a region with a
reticular appearance at one or both ends of the gonad with the
remainder containing cords. The sexual phenotype of weaning age
(,3 weeks postpartum) mice was determined by examining the
external genitalia, noting the anal-genital distance, and observing
whether mammary gland-associated yellow-pigmented hairs were
present [63]. Gonads from E13.5 fetuses were classified at the time of
dissection, when the observer was blind to the fetal genotype. Gonads
without any testicular cords were classified as ovaries, those with
testicular cords only in the central region of the gonad were classified
as ovotestes, and those with testicular cords throughout were classified
as testes. Those with disorganized testicular cords throughout the
gonad were classified as abnormal testes.
Whole-mount immunohistochemistry and RNA in situ
hybridization
Gonad/mesonephros complexes were fixed overnight in 4%
paraformaldehyde in PBS at 4uC. Whole-mount indirect fluores-
cent immunohistochemistry (WIHC) was performed essentially as
previously described [64], except that a blocking buffer containing
3% BSA, 10% donkey serum, 0.1% Triton-X, 0.02% sodium
azide in PBS was used when the anti-PDGFRa or anti-MIS
(AMH) antibodies were employed. Primary antibodies and
dilutions are listed in Table S1. Secondary antibodies were
donkey anti-IgG conjugated with Cy3 or Cy5 (Jackson Immu-
noResearch, 1:500) or AF488 (Molecular Probes, 1:750). Samples
were imaged using a Zeiss LSM510 confocal microscope.
Standard protocols for whole-mount in situ hybridization
(WISH) were used with minor changes [46,65]. Gene-specific
probes are listed in Table S1. The Rec8 probe was synthesized
from a full-length cDNA clone (IMAGE ID:6335959, GenBank:
BC052155.1). Antisense and sense probes were tested in parallel,
and only signal specific to the antisense probes was reported as
gene-specific expression. Each result reported was replicated in a
minimum of four samples.
RNA extraction, reverse transcription, and quantitative
RT–PCR
Total RNA was isolated using the RNeasy mini kit (Qiagen).
Samples were treated with Turbo DNase (Ambion) and subse-
quently treated with DNase inactivation reagent using the DNA-
free protocol (Ambion). RNA Samples were determined to be free
of DNA by PCR using primers specific for the Myog or Lhx1 genes
[29]. cDNA was synthesized using oligo-dT primers and reverse
transcriptase (RT). The RT reaction was tested for the presence of
intact cDNA by PCR amplification with primers specific for the
Hprt transcript [46].
Relative Sry expression in mutant vs. normal gonad/mesonephros
complexes was determined using TaqMan Universal PCR Master
Mix, and Sry (Mm00441712_s1) and Gapdh (Mm99999915_g1)
Assays-on-Demand following the manufacturer’s standard protocol
(Applied Biosystems). Relative Wt1 and Sf1 expression in B6 vs. D2
gonad/mesonephros complexes was determined using Wt1
(Mm00460570_m1), Sf1(Mm00446826_m1) and Gapdh TaqMan
Assays-on-Demand. Relative expression of ovary pathway genes in
B6 vs. D2 ovaries was determined using Power SYBR Green PCR
Master Mix (Applied Biosystems) and the following primers:
Adamts19 (59-CCAGATGCCTCCTGCTTTTA and 59-GGTG-
CGGGTGACCTATGAT: 165 bp product), Wnt4 (59-AGGA-
TGCTCGGACAACATCG and 59-CGCATGTGTGTCAAGA-
TGGC: 149 bp product), Igfbp2 and 1700106J16Rik as in [46], Fst,
Bmp2, and Hprt as in [44], and Irx3 as in [38].
Quantitative RT-PCR (qRT-PCR) assays were performed on
an ABI PRISM 7900HT Sequence Detection System using SDS
2.3 software to determine the average cycle threshold (Ct) value
from three technical replicates for each sample. Average Ct values
for Hprt or Gapdh were subtracted from the average Ct values for
each gene for each sample, to determine the normalized average
Ct value (DCt). When expression was profiled across developmen-
tal stages, the results are represented as expression relative to the
endogenous control gene (22DCt), when expression was compared
within a single developmental stage, the results were determined
by subtracting the average DCt for D2 ovaries according to the
22DDCt method [66]. In pairwise comparisons of gene expression
levels with a priori predictions about the direction of the effect, such
as detecting lower expression of Wt1 and Sf1 or higher expression
of Wnt4 and other ovarian genes in B6 samples, statistically
significant differences were identified by one-tailed unpaired
Student’s t-tests (a=0.05) using Microsoft Excel. For statistical
analysis of Sry expression, one-way ANOVA was used to test for a
significant effect of genotype in multiple comparisons and two-
tailed unpaired Student’s t-tests (a=0.05) in pairwise comparisons
within a developmental stage using JMP version 8 software (SAS
Institute Inc.).
Multi-gene quantitative real time RT-PCR was conducted using
RNA extracted from E12 gonad-mesonephros complexes and E14
gonads as described in [44]. Only E14 XYAKR mutant gonads
lacking any testicular cords (classified as ovaries) were used for this
analysis.
Genotyping assay for the presence of Sf1A172 versus
Sf1S172 alleles
The presence of the Sf1A172 and Sf1S172 alleles was determined
using a previously published genotyping assay [41]. Briefly, a
region of Sf1 exon 3 including codon 172 was amplified from
genomic DNA using 59-TGCGTGCTGATCGAATGC and 59-
CCAGTCGACAATGGAGATAAAGG as primers and the PCR
product digested using NcoI. Genomic DNA containing the Sf1A172
allele contains a NcoI recognition site resulting in two fragments of
331 and 262 bp, while the Sf1S172 allele lacks the NcoI recognition
site resulting in an undigested 593 bp fragment. Genomic DNA
was obtained from mice in the Eicher Laboratory mouse colony or
purchased from the JAX Mice DNA Resource [C58/J (000669),
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NZB/BlNJ (000684), C3H/HeSnJ (000661), BALB/cBY
(000650), SM/J (000687)].
Supporting Information
Figure S1 Transmitted light micrographs illustrating the
phenotypic range of Wt1+/2 B6 XYAKR E15.5 gonads. Only
Wt1+/2 gonad/mesonephros complexes are shown because
Wt1+/2 and Sf1+/2 B6 XYAKR gonads had similar morphology.
All images at 106 magnification, cranial is to the left, and the
gonad is above the dotted black line with the mesonephros below
it. Heterozygous XYAKR ovaries (C) did not have testicular cords,
lacked obvious structure including the coelomic vessel, and were
more similar in size to age-matched +/+ XX ovaries (A) than +/+
XYAKR testes (B). Heterozygous XYAKR ovotestes (D) usually had
central regions with testicular cords (outlined with dotted white
lines) and regions at the cranial (anterior) and caudal (posterior)
poles that lacked obvious structure and appeared to be ovarian.
The regions with cords were associated with a coelomic vessel
(arrowhead) whereas this vasculature was not present in the
flanking regions. The ovary in (C) and the ovotestis in (D) were
present in the same fetus. Some heterozygous XYAKR testes were
slightly abnormal (E) in that they were smaller than +/+ B6
XYAKR testes and appeared to have delayed testis cord formation.
However, these did not contain obvious ovarian tissue. In contrast,
some +/2 B6 XYAKR testes had well-developed cords throughout
(F) and were very similar to +/+ B6 XYAKR testes. The gonads in
(A, B, E, and F) were dissected from fetuses from the same litter.
(TIF)
Figure S2 Expression of ovary-specific markers in B6 XYAKR
E13.5 gonads analyzed by WIHC and WISH. A) WIHC analysis.
FOXL2, which is normally expressed in ovarian somatic cells,
often was expressed in the poles of B6 XYAKR gonads (left panel,
206magnification). In some cases, FOXL2-expressing cells were
found in regions containing AMH-expressing Sertoli cells and
incipient testicular cords (right panel, 406 magnification). B)
WISH analysis. The ovary-specific somatic cell marker Irx3, and
meiotic germ cell markers Stra8 and Rec8 were expressed in the
cranial (anterior) and/or caudal (posterior) poles of B6 XYAKR
gonads. When Stra8 and Rec8 were expressed at both poles in B6
XYAKR gonads at this developmental stage, expression was higher
at the cranial (left) vs. the caudal pole (right). The gonad/
mesonephros complex in each panel is oriented with the gonad
above the mesonephros and the anterior pole to the left.
(TIF)
Table S1 WIHC and WISH markers. Pertinent information on
the antibodies and riboprobes used to analyze morphology and
marker gene expression during fetal gonad differentiation.
(DOCX)
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